Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
Symbol LOXL2 contributors: mct - updated : 27-04-2015
HGNC name lysyl oxidase-like 2
HGNC id 6666
Location 8p21.3      Physical location : 23.154.409 - 23.261.722
Synonym name
  • lysyl oxidase related 2
  • Synonym symbol(s) LOR2, WS9-14
    TYPE functioning gene
    STRUCTURE 107.31 kb     14 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked   status provisional
    Map pter - D8S280 - D8S282 - D8S1739 ,LOXL2 - D8S1725 - D8S278 - qter
    Authors Jourdan-Lesaux (98)
    Physical map
    POLR3D 8q21 polymerase (RNA) III (DNA directed) polypeptide D, 44kDa PIWIL2 8p21.2 piwi-like 2 (Drosophila) SLC39A14 8p21.2 solute carrier family 39 (zinc transporter), member 14 PPP3CC 8p21.2 protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) LOC389639 8 LOC389639 SCAM-1 8p21.2 vinexin beta (SH3-containing adaptor molecule-1) PDLIM2 8p21.2 PDZ and LIM domain 2 (mystique) DBC-1 8p22 p30 DBC protein BIN3 8p21.2 bridging integrator 3 FLJ14107 8p21.2 hypothetical protein FLJ14107 EGR3 8p23-p21 early growth response 3 MGC22776 8p21.2 hypothetical protein MGC22776 RHOBTB2 8p21.2 Rho-related BTB domain containing 2 TNFRSF10B 8p21 tumor necrosis factor receptor superfamily, member 10b LOC389640 8 LOC389640 TNFRSF10C 8p21 tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain TNFRSF10D 8p21 tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain TNFRSF10A 8p21 tumor necrosis factor receptor superfamily, member 10a LOC389641 8 hypothetical gene supported by AK124295 MGC29816 8p21.2 hypothetical protein MGC29816 LOC203069 8p21.2 hypothetical protein LOC203069 LOXL2 8p21.3-p21.2 lysyl oxidase-like 2 LYSAL1 8p22-p21.3 lysosomal apyrase-like 1 MSCP 8p21.2 mitochondrial solute carrier protein PRO1496 8p21.2 hypothetical protein PRO1496 LOC389642 8 LOC389642 NKX3-1 8p21 NK3 transcription factor related, locus 1 (Drosophila) LOC137814 8p21.2 similar to homeobox protein NKX2-6 STC1 8p21-p11.2 stanniocalcin 1
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    14 - 3810 - 774 - 2001 11642359
    - - - - - expressed ubiquitously in cell lines and tissues and mainly localized to the cytoplasm 2014 25275797
  • lacked exon 13 and produced truncated protein
  • promoted the cell mobility and invasion of esophageal squamous cell carcinoma (ESCC) cells to greater degrees
  • may play a very important role in tumor carcinogenesis and progression
    Type ubiquitous
       expressed in (based on citations)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Reproductivefemale systembreast    Homo sapiens
     male systemprostate   
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Connectivebone  highly
    Muscularstriatumskeletal highly
    SystemCellPubmedSpeciesStageRna symbol
    not specificchondrocyte Homo sapiens
    Reproductiveepithelial cell Homo sapiens
    cell lineage
    cell lines
    at STAGE
    physiological period pregnancy
    Text placenta
  • four scavenger receptor cysteine-rich (SRCR) domains in the N-terminus
  • N-glycosylated protein, where N-linked glycans at Asn-455 and Asn-644 that are each essential for protein stability (
  • C-terminal lysyl oxidase (LOX) catalytic domain, sharing extensive homology with the conserved copper-binding and catalytic domains of LOX but lacking a signal sequence
  • conjugated MetalloP
    FAMILY lysyl oxidase family
    CATEGORY enzyme
    basic FUNCTION
  • extracellular, copper-dependent enzyme that initiates the cross-linking of collagens and elastin by catalyzing the oxidative deamination of peptidyl lysine to alpha-aminoadipic-delta-semialdehyde
  • plays an essential role in the formation of extracellular matrix and connective tissue
  • plays a part in epithelial-mesenchymal transition (EMT) by stabilizing the transcription factor SNAI1
  • functions as an amine oxidase for formation of lysine-derived cross-links found in collagen and elastin
  • promotes invasion in breast cancer by regulating the expression and activity of the extracellular proteins tissue inhibitor of metalloproteinase-1 (TIMP1) and matrix metalloproteinase-9 (MMP9)
  • induces epithelial to mesenchymal transition and promotes invasiveness
  • its expression is required for ATDC5 chondrocyte cell line differentiation through regulation of SNAIL and SOX9, important transcription factors that control chondrocyte differentiation
  • promotes chondrocyte differentiation by mechanisms that are likely to include roles as both a regulator and an effector of chondrocyte differentiation
  • likely playing a vital role in chondrogenesis
  • inhibits the differentiation of keratinocytes promoting development of squamous cell carcinomas, but its enzymatic activity is not required for LOXL2-induced inhibition of keratinocyte differentiation
  • having intracellular functions, such as its involvement in the regulation of the epithelial-to-mesenchymal transition, epithelial cell polarity and differentiation mediated by transcriptional repression mechanisms
  • matrix-remodeling enzyme shown to play a key role in invasion and metastasis of breast carcinoma cells
  • tumor- secreted LOXL2 activated fibroblasts through integrin-mediated focal adhesion kinase activation
  • controls tumor-associated cell proliferation through the interaction with MARCKSL1
  • critical intracellular role for LOX and LOXL2 in transcriptional regulation
  • likely regulating extracellular and intracellular cell signaling pathways
  • involved in a wide range of physiological and pathological processes, including fibrosis and tumor progression, implicating intracellular and extracellular functions
    a component
    small molecule metal binding, other,
  • copper Cu2+
  • lysine tyrosylquinone
  • protein
  • interacts and cooperates with SNAI1, a transcription factor, to down-regulate E-cadherin expression that might play a role in tumor progression
  • LOXL2 activity is linked with the transcriptional control of CDH1 gene by regulating H3K4me3 deamination
  • SNAI1 regulates heterochromatin transcription through LOXL2, thus creating the favorable transcriptional state necessary for completing EMT (epithelial-to-mesenchymal transition)
  • MARCKSL1 is a LOXL2 interacting protein (scavenger-receptor domain of LOXL2 was shown to interact with the N-terminal domain of MARCKSL1)
  • is a direct repressor of NOTCH1, and represses NOTCH1 expression in the skin to promote squamous cell carcinoma progression
  • cell & other
    Other its expression is regulated in a temporal manner during fracture repair
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in metastatic breast cancer-derived cell lines
    tumoral     --over  
    in colon and esophageal cancer and may contribute to tumor progression
    tumoral     --over  
    is a frequent event in gastric carcinoma progression (
    tumoral       gain of function
    one of the most highly and specifically upregulated genes in pancreatic cancer
    tumoral     --over  
    correlated with decreased overall survival and metastasis-free survival in breast cancer patients with ERBB2-positive tumors
    Susceptibility to intracranial aneurysm
    Variant & Polymorphism SNP SNP7 showed an empirically significant association with intracranial aneurysm
    Candidate gene
  • may be a beneficial marker for breast cancer patients that could benefit most from anti-ERBB2 therapy
  • Therapy target
    development of anti-LOXL2 therapeutics for the treatment of metastatic breast cancer
    may be a therapeutic target for preventing and treating metastases
    antibody allosteric modulators of enzymatic function represent a novel useful therapeutics in oncology
    antibody allosteric modulators of enzymatic function represent a novel useful therapeutics in inflammation
    improved response toward chemotherapy in LOXL2-silenced pancreatic cancer cells is possibly mediated by the transcription factor E2F5
    target for squamous cell carcinoma progression therapy
  • germ-line deletion of Loxl2 promotes lethality in half of newborn mice mainly associated to congenital heart defects, while Loxl2 overexpression triggers male sterility due to epididymal dysfunction caused by epithelial disorganization, fibrosis and acute inflammation